[ Price : $8.95]
Federal Register notice: In separate rulemakings, FDA proposes to classify into Class 3 certain types of wound dressings and liqui...[ Price : $8.95]
FDA grants fast-track designation to eFFECTOR Therapeutics for its zotatifin in combination with two other drugs as a second- or t...[ Price : $8.95]
Federal Register notices: FDA publishes notices about the regulatory review period determinations for eight drug products sponsore...[ Price : $8.95]
FDA accepts for review a Karuna Therapeutics NDA for KarXT (xanomeline-trospium) for treating schizophrenia in adults.[ Price : $8.95]
Stakeholders comment positively on an FDA draft guidance on developing products to prevent or treat graft-versus-host disease.[ Price : $8.95]
A CDER study examines generic nasal spray distribution factors that could speed the development of generic sprays.[ Price : $8.95]
FDA clears a Vivos Therapeutics 510(k) for its Vivos CARE (Complete Airway Repositioning and/or Expansion) appliances for treating...[ Price : $8.95]
FDA continues to evaluate information about the potential for differences in procedural outcomes between women and men undergoing ...